Trujillo, M.E.; Han, Y.; Baillie, R.A.; Weis, M.C.; Chung, D.; Hayes, S.; Carrington, P.E.; Reed, M.
In Silico Hypothesis Testing in Drug Discovery: Using Quantitative Systems Pharmacology Modeling to Evaluate the Therapeutic Value of Proinsulin Conversion to Insulin Therapy for Type 2 Diabetes Mellitus. Pharmaceutics 2025, 17, 1522.
https://doi.org/10.3390/pharmaceutics17121522
AMA Style
Trujillo ME, Han Y, Baillie RA, Weis MC, Chung D, Hayes S, Carrington PE, Reed M.
In Silico Hypothesis Testing in Drug Discovery: Using Quantitative Systems Pharmacology Modeling to Evaluate the Therapeutic Value of Proinsulin Conversion to Insulin Therapy for Type 2 Diabetes Mellitus. Pharmaceutics. 2025; 17(12):1522.
https://doi.org/10.3390/pharmaceutics17121522
Chicago/Turabian Style
Trujillo, Maria E., Yue Han, Rebecca A. Baillie, Michael C. Weis, Douglas Chung, Sean Hayes, Paul E. Carrington, and Michael Reed.
2025. "In Silico Hypothesis Testing in Drug Discovery: Using Quantitative Systems Pharmacology Modeling to Evaluate the Therapeutic Value of Proinsulin Conversion to Insulin Therapy for Type 2 Diabetes Mellitus" Pharmaceutics 17, no. 12: 1522.
https://doi.org/10.3390/pharmaceutics17121522
APA Style
Trujillo, M. E., Han, Y., Baillie, R. A., Weis, M. C., Chung, D., Hayes, S., Carrington, P. E., & Reed, M.
(2025). In Silico Hypothesis Testing in Drug Discovery: Using Quantitative Systems Pharmacology Modeling to Evaluate the Therapeutic Value of Proinsulin Conversion to Insulin Therapy for Type 2 Diabetes Mellitus. Pharmaceutics, 17(12), 1522.
https://doi.org/10.3390/pharmaceutics17121522
